COMP <GO>
TCMD vs SGHT // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Tactile Systems Technology Inc. (NASDAQ) VS. Sight Sciences Inc. (NASDAQ) • 15-METRIC TALLY: TCMD 8
— SGHT 2
■ METRIC PARITY
LAST: $22.87 (-0.74%) • MKT CAP: $521.9M
options-implied-move
—
LAST: $9.15 (-1.82%) • MKT CAP: $513.4M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TCMD VS. SGHT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TCMD | SGHT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.90% | 86.20% | -10.30 | SGHT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.10% | -35.00% | +52.10 | TCMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.9x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.34% | -5.67% | +13.01 | TCMD | /fcf-yield <GO> |
| Operating Margin | 8.90% | -48.00% | +56.90 | TCMD | /operating-margins <GO> |
| Net Profit Margin | 5.80% | -49.70% | +55.50 | TCMD | /net-margins <GO> |
| Revenue Growth (YoY) | 12.50% | -3.10% | +15.60 | TCMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.38 | 2.16 | +6.22 | TCMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | TCMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.9 | 57.6 | -8.70 | SGHT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $521.9M | $513.4M | $8.5M | TCMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TCMD REV | SGHT REV | TCMD GROSS % | SGHT GROSS % | TCMD FCF | SGHT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $329.5M | $77.4M | 75.9% | 86.2% | $40.4M | -$29.9M |
| FY 2024 | $293.0M | $79.9M | 74.0% | 85.5% | $38.3M | -$22.7M |
| FY 2023 | $274.4M | $81.1M | — | — | $35.9M | -$47.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TCMD // BETA —
SGHT // BETA —